Efficacy, Safety and Tolerability of Sexelaxin When Added to Standard Therapy in AHF

Stopped Study was terminated based on results from pivotal adult AHF study CRLX030A2301

Conditions

• Acute Heart Failure

Interventions

• DRUG: Serelaxin
• DRUG: Placebo
• OTHER: Standard of CareTherapy

Sponsor

Novartis Pharmaceuticals